EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY-NC 4.0

First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study

Angela Kayser, Lukas Lohse, Stephanie Padberg, Brigitte Keller-Stanislawski, Doris Oberle, Evelin Beck, Regina Stegherr, Jan Beyersmann, Katarina Dathe

Clinical Microbiology and Infection · 2025

DOI: 10.1016/j.cmi.2025.06.005 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Angela Kayser und 8 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmaco…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Congenital Abnormalities, COVID-19, Vaccination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bundesministerium für Gesundheit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This observational cohort study evaluates the risk of major birth defects after maternal mRNA COVID-19 vaccination in the first trimester of pregnancy. METHODS: Outcomes of prospectively ascertained pregnancies with at least one mRNA COVID-19 vaccination in the first trimester (gestational week 2 + 0 to 12 + 6) were compared with a cohort of unvaccinated pregnant women of the same period, whose data were collected using the same approach. The enrolment of study cases was conducted over a period of 21 months. For inclusion in the study, a structured pregnancy follow-up had to be completed afterwards. The reported congenital anomalies were classified according to EUROCAT. Relevant maternal characteristics were considered and adjusted ORs were calculated using logistic regression. RESULTS: The exposed study cohort included 1828 pregnant women who were vaccinated with an mRNA vaccine in the first trimester. The unexposed comparison cohort consisted of 1955 pregnant women. Sixty-eight major congenital malformations have been observed in the vaccinated and 53 in the unexposed cohort (3.86% vs. 3.09%). The analysis resulted in an adjusted OR of 1.30 (95% CI: 0.90-1.86). A wide range of performed sensitivity analyses was in line with this finding. CONCLUSIONS: We did not detect a statistically significant increase in the overall birth defect rate after maternal mRNA COVID-19 vaccination in the first trimester.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCongenital AbnormalitiesCOVID-19VaccinationPregnancy Complications, InfectiousHumansFemalePregnancyPregnancy Trimester, FirstProspective StudiesAdultSARS-CoV-2Young Adult

Stichwörter der Autor:innen

COVID-19Congenital abnormalitiesCoronavirusPregnancy outcomePregnancy trimester, firstSARS-CoV-2mRNA vaccines

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Centre of Clinical Teratology and Drug…
  • Division of Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut, Langen, Germany.
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany.
  • Institute of Statistics, Ulm University, Ulm, Germany.

Förderung

  • Bundesministerium für Gesundheit

Zitieren

APA

Kayser, A., Lohse, L., Padberg, S., Keller-Stanislawski, B., Oberle, D., Beck, E., Stegherr, R., Beyersmann, J., & Dathe, K. (2025). First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2025.06.005

Vancouver

Kayser A, Lohse L, Padberg S, Keller-Stanislawski B, Oberle D, Beck E, et al. First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2025.06.005

BibTeX
@article{Kayser2025,
  author = {Kayser, Angela and Lohse, Lukas and Padberg, Stephanie and Keller-Stanislawski, Brigitte and Oberle, Doris and Beck, Evelin and Stegherr, Regina and Beyersmann, Jan and Dathe, Katarina},
  title = {First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study},
  journal = {Clinical Microbiology and Infection},
  year = {2025},
  doi = {10.1016/j.cmi.2025.06.005}
}
Kostenlos starten →